Zenas BioPharma Stock News & Updates

[WKN: A40MUX | Symbol: ZBIO]
Zenas BioPharma

Zenas Biopharma: 56% Efficacy in Phase 3 Study INDIGO Was Not Enough - CEO Takes Advantage of {[Sell-off]} for a $1.6 Million Investment

Analysts' Top 5 Price Targets of October 28, 2025

Upwork [US91688F1049] UBS upgrades rating from Neutral to Buy - price target of $21 (25% upside...

  • ‹
  • 1
  • ›